C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 471/04 (2006.01) A61K 31/437 (2006.01) A61P 35/00 (2006.01) C07D 519/00 (2006.01)
Patent
CA 2610347
The present invention embraces compounds of the general formula (I) in which R2 to R5 and X are as defined in Claim 1, these compounds being suitable for treating diseases characterized by excessive or abnormal cell proliferation, and also embraces their use for producing a medicinal product having the aforementioned properties.
L'invention concerne des composés de formule (I), où R2 à R5 et X sont tels que définis dans la revendication 1, ces composés pouvant servir à traiter des maladies caractérisées par une prolifération cellulaire excessive ou anomale. La présente invention porte également sur leur utilisation pour produire un médicament présentant les propriétés susmentionnées.
Bader Gerd
Betzemeier Bodo
Brueckner Ralph
Guertler Ulrich
Herfurth Lars
Boehringer Ingelheim International Gmbh
Fetherstonhaugh & Co.
LandOfFree
Alpha-carbolines as cdk-1 inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Alpha-carbolines as cdk-1 inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alpha-carbolines as cdk-1 inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1761719